STAT+: Sun Pharmaceuticals to pay $485 million to settle claims its Ranbaxy unit caused customers to overpay for generics
On the eve of a trial, Sun Pharmaceuticals has agreed to pay $485 million to…
Category: Pharma
STAT+: Pharmalittle: FDA rejects Lilly drug studied only in China; AstraZeneca suffers a setback with a key cancer drug
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT+: Pharmalittle: Moderna asks FDA to OK Covid shot for kids under 6; big generic maker to close U.S. plant
Top of the morning to you. Another busy day is unfolding here on the Pharmalot…
STAT+: Aurobindo, major generic drug maker, will close a key U.S. production plant
Aurobindo Pharma, which is based in India and is one of the largest global producers…
STAT+: Pharmalittle: FDA faces immense pressure over an ALS drug; former Biogen R&D chief seeks a reset at another biotech
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT+: Pfizer inks deal with UNICEF to supply Covid pill to poor countries, but advocates say it isn’t enough
As part of an effort to widen access to its Covid-19 pill, Pfizer has reached…
STAT+: ‘Harmful and wasteful’: Many pediatric clinical trials end early or don’t report results
An extensive analysis of thousands of pediatric trials found one in 10 ended early —…
.jpg)
STAT+: Teva and Allergan reach $107 million deal with Rhode Island over opioid crisis
Just as a trial was getting underway, AbbVie and Teva Pharmaceutical reached a settlement worth…
STAT+: Pharmalittle: Covid-19 vaccine market is getting crowded as demand wanes; Russia looks to India to supply pharmaceuticals
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: When should drugmakers go all in and cut off essential medicines to Russia?
Just say nyet? As the war in Ukraine intensifies, several of the world’s largest pharmaceutical…
STAT+: Pharmalittle: Lawmakers face off over FDA’s accelerated approval; ivermectin failed to reduce Covid-19 hospital admissions
And so, another working week will soon draw to a close. This is, as you…
STAT+: Alnylam sues Pfizer and Moderna for patent infringement in development of Covid-19 vaccines
Alnylam Pharmaceuticals has filed separate lawsuits alleging that Pfizer and Moderna infringed its patents in…
STAT+: Pharmalittle: Biogen Alzheimer’s data is published in little-known journal; WHO may reject Medicago Covid shot over ties to Philip Morris
Good morning, everyone, and how are you today? A spot of rain is descending on…
STAT+: A battle is brewing between a senator and a nonprofit over pharma patenting practices
As the pharmaceutical industry faces pointed criticism over its patent practices, an effort appears to…
STAT+: Pharmalittle: Compromise reached on Covid-19 vaccine patent waivers; Biogen reports upbeat data on its Alzheimer’s drug
Hello, everyone, and welcome to the middle of the week. You made it this far,…
.jpg)
STAT+: Lawmakers accuse PhRMA of providing ‘misleading information’ about drug price hikes
A group of Congressional lawmakers is accusing the pharmaceutical industry’s leading trade group of providing…
STAT+: A compromise is reached on an intellectual property waiver for Covid-19 vaccines, but does it go far enough?
After 18 months of talks, a compromise was reached on a proposal to waive intellectual…
STAT+: Gilead faces criticism for donations to state senators who backed ‘Don’t Say Gay’ bill in Florida
There was a curious dichotomy underlying the outcry over the so-called ‘Don’t Say Gay’ bill…
STAT+: Pharmalittle: Congress wants opioid-settlement tax breaks probed; another yawner of a drug-pricing hearing?
Hello, everyone, and how are you today? A shiny sun is warming the Pharmalot campus,…
STAT+: Arrowhead shareholders urged not to approve ‘excessive’ compensation for non-executive directors
In an unusual move, a prominent shareholder advisory firm is urging investors in Arrowhead Pharmaceuticals…
STAT+: Watcdog says Lilly made ‘false assertions’ about impact of pausing political donations after Jan. 6 attack
Early last year, Eli Lilly (LLY) temporarily halted contributions made to members of Congress who…
STAT+: Pharmalittle: Patient groups pressure Medicare over Alzheimer’s drug; pharma says it’s duty-bound to sell meds in Russia
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Combination treatment from Nektar and Bristol Myers Squibb fails to benefit patients with melanoma, study shows
Nektar Therapeutics said Monday that its experimental immunotherapy failed to provide additional benefit for patients…
He was creating the building blocks for drug developers worldwide. Then Russia started to bomb Kyiv
It was just last month, with the Covid-19 situation having calmed down in Kyiv, that…
STAT+: Cutting-edge gene therapies could be coming for sickle cell. Will Medicaid patients be able to access them?
Gary Puckrein sees a dilemma coming that has him excited, and at the same time,…
STAT+: Pharmalittle: Opioid victims and their families berate Sacklers in court hearing; Glaxo shingles vaccine campaign in U.K. is criticized
And so, another working week will soon draw to a close. Not a moment too…
‘Scum of the earth’: Opioid crisis victims face Purdue Pharma owners
NEW YORK — Releasing years of anguish and anger, victims of opioid abuse and those…
STAT+: Pharmalittle: Bankruptcy court judge OKs Purdue settlement; U.S. Senate revives legislation to curb insulin costs
Rise and shine, another busy day is on the way. However, this is also shaping…
STAT+: Dozens of towns and counties object to ‘hush money’ tied to Purdue opioid settlement
Ahead of a bankruptcy court hearing to approve a $6 billion settlement with Purdue Pharma…
STAT+: Pharmalittle: Insurers balk at opioid payouts to drugmakers and wholesalers; AbbVie settles another Humira biosimilar lawsuit
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT+: AbbVie settles litigation with another drug maker over a biosimilar version of Humira
After months of squabbling over allegedly stolen trade secrets, AbbVie (ABBV) has settled litigation with…
STAT+: Mallinckrodt to pay $260 million to settle federal lawsuits over Medicaid rebates and kickbacks
After years of squabbling, Mallinckrodt agreed to pay $260 million to settle accusations that it…
STAT+: Pharmalittle: U.S. lawmaker proposes bill to curtail FDA’s accelerated approval; Moderna to enforce Covid patents in wealthy countries
Top of the morning to you. A shiny sun is enveloping the Pharmalot campus this…
STAT+: Moderna looks to enforce its Covid-19 vaccine patents in wealthy countries
Amid intense public pressure, Moderna (MRNA) updated a pledge not to enforce patents for its…
Opinion: The U.S. must fix its innovation engine: the patent system
If your car starts to smoke and sputter, you’d take it to an auto repair…
STAT+: FDA effort to improve clinical trial diversity failed to make a difference for Black patients, study finds
Six years ago, the U.S. Food and Drug Administration launched a five-year action plan to…
STAT+: Few public biotech companies disclose environmental, social, and governance steps
Environmental, social, and governance issues are gaining greater attention among investors, but only 30% of…
STAT+: Pharmalittle: White House bid for Covid drug funding hurt by transparency issue; Bluebird Bio runs short of cash
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: An international treaty is needed to prevent countries from banning exports of medical products, experts urge
Amid increasing concern over shortages of medical products, a new study recommends that the United…
STAT+: ViiV causes an outcry by declining to pursue voluntary licensing for its HIV prevention shot
In a surprise move, ViiV Healthcare has decided not to license its long-acting injectable HIV…
STAT+: Pharmalittle: Sacklers and states agree to $6 billion opioid settlement; Biogen layoffs get under way
And so, another working week will soon draw to a close. Not a moment too…
Opinion: Finding cures faster: Bring the FDA into the 21st century with advanced testing
From every sector, the cry is being raised: “We can’t go back to the way…
STAT+: Washington state moves closer to creating the next prescription drug affordability board
In a closely watched development, House lawmakers in Washington state passed a bill to create…
Sacklers agree to $6 billion Purdue bankruptcy settlement over opioid crisis
The Sackler family members who own Purdue Pharma have agreed to a $6 billion settlement…
STAT+: Pharmalittle: U.S. will share some coronavirus technologies with WHO; Civica Rx tries unconventional bid to make cheap insulin
Top of the morning to you, and a fine one it is. A shiny sun…
STAT+: Civica Rx has an ambitious plan to make low-cost insulin for all Americans. But can it work?
In an unconventional bid to widen access to insulin for Americans, a nonprofit announced plans…
STAT+: Nevada joins a little-known, ambitious state consortium dedicated to better drug prices
After months of talks, the state of Nevada has joined a consortium formed by Oregon…
STAT+: Pharmalittle: U.S. Supreme Court examines when misprescribing is criminal; Biden calls for capping insulin at $35
Top of the morning to you. Another busy day is unfolding here on the Pharmalot…
STAT+: Tennessee judge sanctions Endo for ‘coordinated strategy’ to withhold documents in opioid case
Endo International (ENDP) was sanctioned by a Tennessee state court judge for using a “coordinated…
STAT+: Pharmalittle: Broad Institute wins legal battle over CRISPR patents; Pfizer’s C. diff vaccine fails in study
Good morning, everyone, and how are you today? We are doing just fine, thank you,…